Project Details
Description
A randomized, open-label, multi-center, comparative trial, to assess the efficacy and safety of pritelivir versus foscarnet for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised subjects (PRIOH-1)
| Status | Active |
|---|---|
| Effective start/end date | 7/25/23 → 7/31/33 |
Funding
- AICURIS GMBH & CO KG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.